|
Physician.com promises to be the #1 destination for high tech physicians and discerning patients on the Internet today.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From the Staff at Physician.com
|
|
|
Physician.com is now offering a "Money for Doctors" section on our website to help doctors find funding for their offices and services. We understand how difficult it can be to maintain a state of the art office for your patients and the high expense of purchasing new equipment that will help your patients live a more rewarding life.
Let Physician.com help you with funding your office and sleep better at night knowing that we can help you with your needs today.
|
|
Canadian Scientists Report On Pain Research At NIDCR's 60th Anniversary Symposium
Nearly everyone has experienced the acute, short-lived pain that occurs after a mild injury, but recent surveys reveal that more than 20% of the population has a chronic pain condition (i.e., pain that has lasted for 3 months or more) and for which treatment is often not very effective (e.g., low back pain, fibromyalgia, migraine headaches). Acute and chronic pain conditions have huge socio-economic costs.
NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine
NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development.
Migraine Mutations Reveal Clues To Biological Basis Of Disorder
Fifteen percent to 20 percent of people worldwide suffer from migraines excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder. In the Proceedings of the National Academy of Sciences, Alfred George Jr., M.D.
Zogenix Announces Clinical Study Results For Sumatriptan DosePro™, A Novel Migraine Treatment
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
Merck's Investigational Migraine Treatment Telcagepant Improved Pain And Migraine-Associated Symptoms In Phase III Study
Merck & Co., Inc. announced that, in a Phase III clinical trial, telcagepant (formerly MK-0974), its investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist, significantly improved relief of migraine pain and migraine-associated symptoms two hours after dosing compared to placebo.
Data On Highly Effective Migraine Treatment Presented By OptiNose
OptiNose has announced that it presented important new data demonstrating the superior performance of its novel nasal drug delivery device with sumatriptan for the treatment of migraines. The Phase II results indicate that the drug-device combination achieves migraine relief as quickly and efficiently as injections without the discomfort, inconvenience and risk of needle-stick injuries. OptiNose presented the data at the Annual Scientific Meeting of the American Headache Society in Boston.
MAP Pharmaceuticals Reports Positive Pharmacological Response Data For Migraine Product Candidate At The American Headache Society Annual Meeting
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) presented data from an in-vitro study evaluating receptor pharmacology of MAP0004, orally inhaled dihydroergotamine (DHE) for the potential treatment of migraine, compared to intravenous (IV) DHE. The study results were among six posters relating to the MAP0004 program that the Company presented at the American Headache Society 50th Annual Scientific Meeting in Boston, MA.
Migraine "Gun" Zaps Pain With The Touch Of Button - FDA Close To Approving Device That Uses Magnetic Bursts To Stop Pain
There are some 30 million Americans who suffer from migraine headaches.* Researchers at Ohio State University Medical Center have unveiled a new device that can control the pain of migraine headaches with no drugs, no injections, and no side effects. In fact this device is as easy as touching a button. After nearly eight years of development the migraine zapper could be on the market in a matter of months.
Medtronic Announces First Clinical Data On Occipital Nerve Stimulation For Chronic Migraine
Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, singleblinded, Controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS) tomorrow in Boston.
Knowledge And Understanding Ease Headache Frustrations
Headache frustrations are set to ease, thanks to a new range of patient leaflets. Produced by Lifting The Burden, the World Health Organization's Global Campaign to Reduce the Burden of Headache Worldwide, they will help sufferers understand and manage their headache more effectively. Almost all of us will have had a headache, but for many people it is more than just an irritant.
Portable Device Effective In Zapping Away Migraine Pain
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center. Results of the study, presented TODAY (6/27) at the annual American Headache Society meeting in Boston, found that the experimental device is safe and effective in eliminating headaches when administered during the onset of the migraine.
Headache Specialists Convene In Boston For 50th Annual American Headache Society Meeting
Headache specialists meet in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.
Alexza Pharmaceuticals To Present AZ-104 Phase 2a Clinical Data At The American Headache Society Annual Scientific Meeting
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting of the American Headache Society, which being held at the Marriott Boston Copley Place in Boston, MA.
Treating Chronic Pain, Migraine & Muscle Spasticity Through Inhibition Of Neurotransmitter Glutamate
A Webinar hosted by TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of the neurotransmitter glutamate. The company's President and Chief Executive Officer, Neil Kurtz, M.D., will moderate a discussion following brief presentations by: Tony Yaksh, Ph.D.
Shower Curtains Can Be Toxic Says Environment Group
A US health and environment group is calling for major retailers such as Wal-Mart to phase out PVC shower curtains, and for the authorities to recall the products from sale because a laboratory study showed they released toxic chemicals into the air.
Migranes And Sleep Disorders Linked In Children
Children with a migraine headache are more likely to have sleep disorders, such as obstructive sleep apnea (OSA) and lack of sleep, than children without a migraine, according to a research abstract on the effects of headaches on children's sleep patterns presented on Tuesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Nagging Headache Often Linked To Dental Pain
Could that nagging headache and painful jaw be tied to your oral health? Many headache sufferers might want to consult their dentist as well as their doctor since headaches and dental pain have a lot in common, says Director of the Orofacial Pain and Oral Medicine Graduate Program at the USC School of Dentistry Glenn Clark.
Office Initiative Reduces Headaches And Neck And Shoulder Pain By More Than 40 Per Cent
Office staff who took part in an eight-month workplace initiative reported that headaches and neck and shoulder pain fell by more than 40 per cent and their use of painkillers halved, according to research published in the May issue of Cephalalgia. They also reported that pain levels were less severe at the end of the study than at the start.
FDA Approves New Class Of Migraine Drug
If you're one of the nearly 30 million Americans* who suffers from migraine headaches, you now have a new way to fight them. This month, a new drug is expected to land in pharmacies that combines two existing migraine drugs. Most days, Richard Higgins is very active. If he's not training for triathlons, he's doing karate with his kids. The only thing that seems to slow him down is his migraine headaches.
ROXRO PHARMA Announces Positive Clinical Proof Of Concept Results For Novel Intranasal Migraine Treatment
ROXRO PHARMA, Inc. announced positive top-line data from a clinical study of the company's novel investigational intranasal pain reliever in the treatment of migraine and related symptoms. The placebo-controlled proof of concept study evaluated the efficacy and safety of ROX-828, an intranasal formulation of the non-steroidal anti-inflammatory (NSAID) pain reliever ketorolac.
Sensitive Skin A Symptom Of Migraine
"Migraine hurts skin" is the headline in the Daily Mirror. The newspaper describes the symptom of sensitive skin, called allodynia, where sufferers of migraine find combing their hair, wearing jewellery or getting dressed "excruciatingly painful". The newspaper reports that 10% of people in the UK suffer migraine. The Daily Telegraph covers the same story and suggests "two thirds of migraine sufferers reported symptoms of the condition allodynia".
Migraine Increases Risk Of Severe Skin Sensitivity And Pain
People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one's head, combing one's hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Teva Announces Tentative Approval Of Generic Maxalt(R) Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Merck's migraine pain treatment Maxalt® (Rizatriptan Benzoate) Tablets, equivalent to 5 mg and 10 mg base. Final approval of this product is anticipated upon expiration of patent protection for the brand product in June 2012.
Treximet (sumatriptan And Naproxen Sodium) Tablets Approved By FDA For Acute Treatment Of Migraine
GlaxoSmithKline (LSE & NYSE: GSK) and POZEN Inc. (NASDAQ: POZN) announced that the FDA has approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines pioneered by GSK, and an anti-inflammatory pain reliever in a single tablet.
Concentrating On Different Aspects Of Pain Leads To Breakthrough In Migraine Genetics
In a new study, published in the American Journal of Human Genetics, researchers were able for the first time to convincingly demonstrate a genomic locus to be linked to migraine susceptibility in two diverse populations. Migraine is the most common cause of episodic headache, and by far the most common neurological cause of a doctor's visit.
|
|
|
 |
|
Medicare Adds Third Recognized Source To Help Determine Coverage For Anti-Cancer Chemotherapy Drugs
The Centers for Medicare & Medicaid Services (CMS) announced additional updates to the information it uses in determining which drugs may be covered under Medicare Part B when used to treat patients undergoing cancer treatment through chemotherapy. CMS will add Elsevier Gold Standard's Clinical Pharmacology compendium to the list of Medicare anti-cancer treatment compendia.
3rd ESU Masterclass Presents Insightful Updates On Urological Oncology
Insightful updates on onco-urological issues were the focus of the 3rd ESU masterclass, which started in Barcelona on Friday 27 June. There were 150 participants who listened to a faculty of 12 internationally renowned experts in urological cancers. The European Board of Urology (EBU) organised a written examination following the masterclass which is accredited within the EU-ACME programme.
Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Advanced Thyroid Cancer Investigational Drug Shows Promise
A study by an international team of researchers found that an experimental drug that stops blood vessels that feed tumors from forming was able, in a small number of patients, to slow down the progression of advanced thyroid cancer that has spread to other sites.
Fourth Annual Symposium On Liver-Directed Microsphere Therapy Raises Awareness Of The Latest Advances For Treating Metastatic Liver Tumors
More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy. The symposium, sponsored by the Goshen Center for Cancer Care, was supported by an educational grant provided by Sirtex Medical. Sirtex manufactures SIR-Spheres microspheres, the only FDA-approved microsphere therapy for colorectal liver metastases.
Oncolin Therapeutics Announces The Discovery Of A New More Effective Anti-Cancer Treatment In Experimental Brain Tumor Models
Oncolin Therapeutics, Inc., (OTCBB:OCOL) announces that a team of scientists supported by an Oncolin Sponsored Research Agreement (SRA) and lead by Professor Waldemar Priebe from The University of Texas M. D. Anderson Cancer Center (UTMDACC) has discovered a new inhibitor of glycolysis, which is superior to the other known inhibitors. These results were confirmed both in vitro as well as in vivo brain tumor models.
Targeted Therapies To Lead New Wave Of Breast Cancer Treatments
Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from Frost & Sullivan, U.S.
Potential New Ways To Treat Metastatic Cancer Following Discovery Of Gene Mechanism
Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease.
Researcher Using Computers To Hone Cancer Fighting Strategies
A Florida State University faculty member who uses computational techniques to evaluate a new class of cancer-killing drugs is attracting worldwide attention from other researchers. Kevin C.
Doctor Knowledge Of Cancer Treatment Options, Costs Key To Advising On Proper Medical Care
The growing number of cancer treatment options and their widely varying costs suggest an increased need for oncologists to understand economic issues in cancer care and be able to discuss these issue with their patients, according to a study by researchers at the University of Texas M.D. Anderson Cancer Center and RTI International.
Texas Oncology Urges Texans To 'Save Your Skin:' Outsmart The Sun And Prevent Skin Cancer
Now that school is out and the first day of summer is upon us, the cancer care experts at Texas Oncology remind Texans to "save your skin" by outsmarting the sun when spending time outdoors. Although the most prevalent cancer in the United States today, skin cancer is also the most preventable. The majority of the more than 1 million annual U.S. cases of skin cancer are sun-related.
Scientists Predict Three Quarters Of Children With Leukaemia In The UK Will Be Cured
Around three-quarters of children diagnosed with leukaemia will be cured of their disease, according to research published in the British Journal of Cancer* .
Mediterranean Diet Cuts Cancer Risk
Adopting just two aspects of the Mediterranean diet can cut the risk of developing cancer by 12 per cent - research published in the British Journal of Cancer* reveals.
Pharmacists Urge Consumers To Seek Advice About Sunburn Safety
With the incidence of skin cancer annually on the rise, the American Pharmacists Association (APhA) encourages consumers to talk to their pharmacist about sunburn prevention, sunburn treatment and medications that increase the skin's sensitivity to the sun. Besides being medication experts, pharmacists are also knowledgeable about how to prevent and treat common summertime ailments, such as sunburns.
Clinicians Should Consider Economic Impact Of New Interventions
Cancer clinicians should understand and consider the economic impact of new interventions, which often have substantial costs, according to a report appearing in the July/August issue of CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society.
Newly Discovered Checkpoint Process Decides Between Death, Division Or Cancer
Each day, a staggering number of cells perform a feat that still amazes researchers with its complexity: they divide to produce perfect replicas of each other. The process is called mitosis, and an inability to control it is one of the hallmarks of cancer.
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston. Findings were published online on June 29 by the journal Nature Biotechnology.
Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem In Pediatric Cancer Research
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
Is Pelvic Lymph Node Dissection Necessary Among Elderly Patients With Bladder Cancer Undergoing A Radical Cystectomy?
ORLANDO, FL (UroToday.com) - Extension of the pelvic lymph node dissection (PLND) during radical cystectomy (RC) has been proposed to improve patient survival and optimize lymph node count, a potential indicator of surgical quality. Yet, the survival benefit for elder patients with decreased life expectancy is unclear. The authors assessed the impact of PLND on the overall survival (OS) of elder bladder cancer patients undergoing RC.
Sunburn Alert: UVB Does More Damage To DNA Than UVA
As bombs burst in air this July 4, chances are that sunburn will be the red glare that most folks see - and feel. But unfortunately, even when there is no burn, the effects of the sun's ultraviolet (UV) rays can have deadly consequences. Thanks to a new research study published in the July 2008 issue of The FASEB Journal, scientists now know why one type of UV light (UVB) is more likely to cause skin cancer than the other (UVA).
DxS Launches Cancer Mutation Kit For K-RAS In Australia - New Diagnostic Assists Clinicians In Selecting Appropriate Cancer Therapy For Patients
DxS, a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the launch of its K-RAS cancer mutation detection kit in Australia. This follows the kit meeting the compliance standards of Australia's Therapeutic Goods Administration (TGA).
Yeast-Based Vaccine Induces Immune Responses And Reduces Tumor Size In Mice
Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice. Vaccination extends overall survival and reduces tumor size in mice that have been injected with cancer cells displaying the same protein that was engineered into the yeast.
Pseudosarcomatous Fibromyxoid Tumor Of The Bladder
UroToday.com - We recently reported on the workup and treatment of a benign bladder lesion termed pseudosarcomatous fibromyxoid tumor of the bladder. One of goals of the manuscript was the description of conservative surgical treatment of localized bladder lesions, which could be malignant or benign. Benign lesions include leiomyoma, pseudosarcomatous fibromyxoid tumor, among others.
Prognostic Impact Of Postoperative C-Reactive Protein Level In Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
UroToday.com - The presence of a systemic inflammatory reaction, represented by C-reactive protein (CRP), has been recognized as one of the negative prognostic factors in various malignancies. In genitourinary cancers our group and others have demonstrated that an increase in pretreatment CRP is a negative prognostic factor in patients with renal cell carcinoma 1-4 as well as in those with upper urinary tract urothelial carcinoma.
How To Move Cancer Research Forward: Public/Private Partnerships - A NCI Science Writer's Seminar
Whatbr> Please join us for a science writers' seminar to discuss public/private partnerships in cancer research. Among the topics discussed will be working with industry to develop new drugs; cancer vaccine development and business barriers; working with small businesses to develop new technologies to catch cancer in its earliest stages; and intellectual property rights and technology transfer issues related to new genetic tests.
|
|
|
|
OneTouch® Ping™ Glucose Management System Cleared By FDA
Animas Corporation announced the clearance of its OneTouch® Ping™ Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.
Long-Term Study Of Middle-Aged Mice Shows Resveratrol Improves Health And Mimics Some Benefits Of Dietary Restriction
Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, is included among a research team that reported in today's online edition of Cell Metabolism that mice treated at middle-age to the end-of-life with resveratrol showed an overall health improvement, including improved bone health, a reduction in cataracts and cardiovascular dysfunction, and improved balance and motor coordination.
Special Diabetes Program
Volunteers representing the Juvenile Diabetes Research Foundation International (JDRF), the American Diabetes Association (ADA) and the National Indian Health Board (NIHB) have presented Senator Byron Dorgan with the 2008 Congressional Leadership Award for his leadership on extending the Special Diabetes Program (SDP) in Congress.
Metabolomics Sheds New Light On The Question "Healthy Or Diseased?"
Metabolomics aims to determine the totality of all small molecules of a cell or a tissue. The exponents of bioinformatics analyzed data collected in the framework of a pre-clinical metabolomics study in healthy and diabetic mice. In each case, a subgroup of the animals was treated with the diabetes drug RoziglitazoneTM.
California Summit Focuses On Diabetes, Obesity In Minority Communities
The California Legislative Black Caucus Foundation and Assembly member Sandre Swanson (D) on Friday sponsored a health care summit that focused on ways to address diabetes and obesity, particularly in minority communities, the Contra Costa Times reports.
Better Glucose Control In Children With Type 1 Diabetes Associated With Dietary Adherence
A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes. "In recent years, diabetes management has been focused around new medications and technologies," said Lori Laffel, M.D., senior author of the paper, which is published in the July issue of Diabetes Care.
1000 Healthcare Professionals Expected At The Diabetes Asia 2008 Conference
More than 1000 local and foreign participants are expected to attend the "Diabetes Asia 2008" Conference to be held in a resort hotel convention centre, Petaling Jaya for four days from October 23-26, 2008. The Conference is organised by the National Diabetes Institute (NADI) as a "Continuing Professional Development (CPD)" activity for healthcare professionals caring for people with diabetes.
New Discovery A Step Towards Better Diabetes Treatment
In the prestigious journal Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin. The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.
Diabetic Hypoglycaemia: ESP Bioscience Announces New Journal For 2008 (01 July 2008)
ESP Bioscience today announced the forthcoming launch of Diabetic Hypoglycaemia (www.hypodiab.com), an influential new online diabetes journal delivering a range of hypoglycaemia information, including: background science, human physiology, and clinical and educational communications.
OneTouch(R) Ping(TM) Glucose Management System Cleared By FDA
Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.
Echo Therapeutics Initiates Clinical Study Of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System In Patients With Diabetes
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008.
News From The Annals Of Internal Medicine July 1, 2008
1. Benefits of Tight Glucose Control Remain Uncertain for Older Diabetics In a computer modeling study, researchers set out to assess the effects of comorbid illnesses and functional status on the expected benefits of intensive glucose control.
The Underlying Molecular Mechanism For Hypertension, Insulin Resistance And Other Metabolic Complications Identified
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
VIVUS Announces New Data From Qnexa Diabetes Study
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced additional data from the 28-week Qnexa phase 2 study (OB-202) in type 2 diabetics. A subset analysis of subjects with higher cardiovascular risk factors at baseline had significantly greater improvements on Qnexa as compared to placebo.
Link Between Starvation And Growth Hormone May Be Clue To Increasing Life Span, Researchers Find
Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span. "It's been well-established that growth is blunted during starvation. But our work shows that this is not just from running out of energy. It's much more sophisticated than that," said
Volunteering Opportunities For Healthcare Professionals
The Care Events team at Diabetes UK is looking for healthcare professionals to volunteer on its holidays and weekends for people with diabetes. If you have diabetes or an interest in diabetes and have the right skills and expertise that can be used on our events, we encourage you to apply.
ARKRAY USA Receives FDA Clearance On GLUCOCARD(TM) 01 Blood Glucose Monitoring System
ARKRAY USA, Inc. announced 510(k) clearance on GLUCOCARD(TM) 01 Blood Glucose Monitoring System. GLUCOCARD(TM) 01 This new, affordable system requires no coding, displays results in 7 seconds, and requires a tiny 0.3 microliter sample size. GLUCOCARD(TM) 01 is AST approved and has a 360-count test memory with time and date stamp. It also features a large, easy-to-read display for better viewing of test results.
Diet Impacts Brain Function In Seniors With Type 2 Diabetes
Adults with type 2 diabetes who eat unhealthy, high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research from Baycrest. There is already growing evidence linking diabetes to cognitive complications in humans. Adults with type 2 diabetes are especially vulnerable to acute meal-induced memory deficits after eating unhealthy foods.
LCT Informed Of Progress For Decision On Diabetes Clinical Trial In New Zealand
Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) announced that it has received a letter from the New Zealand Minister of Health, the Honorable David Cunliffe, indicating that he has sought independent advice from the National Health Committee (NHC) by 8 August 2008, on LCT's application to conduct a Phase I/IIa clinical trial with DiabeCell® in New Zealand.
Preventative Care The Standard To Treat New Diabetics
The Centers for Disease Control and Prevention recently reported that the number of Americans with diabetes has grown to 24 million - a surge of more than 3 million people in the past two years. That surge is evident at Temple University's School of Podiatric Medicine, where podiatrists have seen a spike in recently diagnosed diabetic patients who have been referred by their primary care physician as part of a heightened awareness of the disease.
Alimera Reports Results From The Three-Month Interim Readout Of The Human PK Medidur(TM) FA Study
Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, reported the interim month three safety and efficacy results from the first human pharmacokinetic (PK) study of Medidur(TM) FA, which Alimera Sciences intends to market under the tradename Iluvien(TM), if approved by the U.S. Food and Drug Administration.
Osiris Therapeutics Announces 2 Million Dollars Milestone Payment For Clinical Progress Of A Stem Cell Therapy For Type 1 Diabetes
Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for patients recently diagnosed with type 1 diabetes. The payments were triggered when Osiris accomplished certain clinical and regulatory milestones including initiating patient treatments.
Diabetes UK Becomes The First Charity To Create An Equality And Diversity Team
Diabetes UK has become the first charity in the UK to create an Equality and Diversity team. The team is dedicated to helping diverse groups including black, Asian and minority ethnic communities, people with learning disabilities, prisoners and gypsies. The team includes four Diverse Community Officers (DCOs) who each cover London, the South East, West Midlands and the North West and are led by Diabetes UK Equality and Diversity Manager Jenne Dixit.
Number Of People With Diabetes Increases By 15%; Minorities Disproportionately Affected By Condition
An estimated 24 million U.S. residents have diabetes, a 15% increase from two years earlier, according to a CDC report released on Tuesday, Bloomberg/Philadelphia Inquirer reports (Lopatto, Bloomberg/Philadelphia Inquirer, 6/25). About 8% of the U.S.
Have You Been Diagnosed With Type 2 Diabetes In The Last Year? UK
Have you been diagnosed with Type 2 diabetes in the last 12 months? If so we'd like you to potentially take part in a study to ask you about your views and experiences of Type 2 diabetes. If selected, you will be reimbursed for your time and travel expenses.
|
|
|
|
|